Cell Therapy Process Development & Scale-Up
Turning a lab protocol into a reliable, scalable process for clinical use ensures your cell therapy can move efficiently toward the clinic. At Cell-Easy, we work with your teams to make the transition to GMP smoother.
We focus on designing manufacturing processes that are robust and aligned with regulatory expectations.
Process Development Track Record in Figures
50+
Processes Developed
95%
Scale-up success rate
Our Approach: Turning Lab Protocols into GMP-Ready Processes
Every therapy is different, but the objective is the same: moving from a lab process to a process that meets GMP standards and clinical expectations. We guide you through each step, ensuring your process is built for long-term success.
Assessing Your Process for GMP Readiness
We start by taking a deep look at your manufacturing process to identify risks and opportunities for improvement.
- Workflow audit assessing reproducibility, materials, and alignment with regulatory expectations.
- Variability mapping identifying potential hotspots and verifying that reagents and consumables meet GMP requirements.
- Regulatory mapping aligning your process with cGMP and international guidelines.
What you gain: A clear roadmap highlighting where your process may fall short, so you can focus on fixing gaps before they impact GMP readiness or regulatory submissions.
Securing Materials and Cell Banks
Quality starts with what goes into your process. We secure and qualify all materials to ensure a strong and reliable foundation.
- Clinical-grade sourcing through trusted hospital, blood bank, and global supplier partnerships.
- ICH-compliant cell banks including PCB, MCB, and WCB to ensure consistency and traceability.
- Donor eligibility frameworks designed to meet regulatory expectations and minimize risk.
What you gain: Consistent, high-quality starting materials that prevent production interruptions and ensure your therapy meets regulatory standards from day one.
Optimizing and Scaling Your Manufacturing Process
This is where your manufacturing process takes shape for the clinic. We refine and scale your workflow step by step to ensure it performs consistently at every level.
- Optimization of isolation, expansion, harvest, and cryopreservation for improved reproducibility and reduced contamination risks.
- Design of Experiments (DoE) and CQA/CPP monitoring to fine-tune control and stability.
- Scalable, automated platforms built to accommodate future needs and growth.
What you gain: Improved yields, reproducibility, and scalable operations, allowing faster, smoother progression to clinical manufacturing.
See how we approach process development at Cell-Easy : Quality by Design Reveals What Standard Process Development Misses
Your Partner in Cell Therapy Process Development
When you work with Cell-Easy, you’re not just outsourcing to a CDMO, you’re teaming up.
We become an extension of your team, fully committed to helping your cell therapy reach patients safely, efficiently, and on schedule.
- Dedicated support for your therapy: We make sure you have clarity every step of the way with weekly updates, quarterly strategic reviews with a senior leader, and a dedicated project manager guiding your project.
- Proven track record: We have supported over 50 cell therapy development programs, demonstrating consistent results.
- Transparent collaboration: Through clear planning and Go/NoGo assessments, we keep your project on track without surprises.
- Accelerated IND/IMPD support: Our approach can shorten submission timelines by up to three months.
- Regulatory compliance & traceability: We ensure that your cell therapy meets international standards at every stage.
Discover more
GMP Cell Banking
GMP manufacturing
Analytical Development